Novolog Pharm-Up 1966 Ltd (NVLG) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Novolog Pharm-Up 1966 Ltd (NVLG) has a cash flow conversion efficiency ratio of -0.120x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-44.21 Million ≈ $-118.53K USD) by net assets (ILA368.90 Million ≈ $989.02K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Novolog Pharm-Up 1966 Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how Novolog Pharm-Up 1966 Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Novolog Pharm-Up 1966 Ltd for a breakdown of total debt and financial obligations.
Novolog Pharm-Up 1966 Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Novolog Pharm-Up 1966 Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
GOLCONDA GOLD LTD
F:Y87
|
0.075x |
|
Hod Assaf Industries Ltd
TA:HOD
|
-0.088x |
|
Iljin Power Co. Ltd
KQ:094820
|
0.032x |
|
Chien Shing Harbour Service Co Ltd
TW:8367
|
0.094x |
|
Kutahya Seker Fabrikasi AS
IS:KTSKR
|
-0.005x |
|
Silver Pegasus Acquisition Corp.
NASDAQ:SPEG
|
-0.001x |
|
Kc Cottrell
KO:119650
|
-0.341x |
|
Cantor Equity Partners, Inc. Class A Ordinary Shares
NASDAQ:CEP
|
N/A |
Annual Cash Flow Conversion Efficiency for Novolog Pharm-Up 1966 Ltd (2014–2025)
The table below shows the annual cash flow conversion efficiency of Novolog Pharm-Up 1966 Ltd from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Novolog Pharm-Up 1966 Ltd worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ILA368.90 Million ≈ $989.02K |
ILA-16.50 Million ≈ $-44.24K |
-0.045x | -110.78% |
| 2024-12-31 | ILA382.14 Million ≈ $1.02 Million |
ILA158.52 Million ≈ $424.98K |
0.415x | -17.85% |
| 2023-12-31 | ILA396.12 Million ≈ $1.06 Million |
ILA200.01 Million ≈ $536.23K |
0.505x | +75.88% |
| 2022-12-31 | ILA462.05 Million ≈ $1.24 Million |
ILA132.65 Million ≈ $355.62K |
0.287x | +48.12% |
| 2021-12-31 | ILA430.23 Million ≈ $1.15 Million |
ILA83.39 Million ≈ $223.56K |
0.194x | -2.01% |
| 2020-12-31 | ILA295.67 Million ≈ $792.68K |
ILA58.48 Million ≈ $156.80K |
0.198x | -48.57% |
| 2019-12-31 | ILA263.78 Million ≈ $707.18K |
ILA101.45 Million ≈ $271.99K |
0.385x | +63.10% |
| 2018-12-31 | ILA101.61 Million ≈ $272.42K |
ILA23.96 Million ≈ $64.24K |
0.236x | -76.60% |
| 2017-12-31 | ILA85.71 Million ≈ $229.79K |
ILA86.37 Million ≈ $231.56K |
1.008x | +251.15% |
| 2016-12-31 | ILA70.68 Million ≈ $189.49K |
ILA20.28 Million ≈ $54.38K |
0.287x | -79.07% |
| 2015-12-31 | ILA102.34 Million ≈ $274.37K |
ILA140.29 Million ≈ $376.12K |
1.371x | -25.93% |
| 2014-12-31 | ILA86.77 Million ≈ $232.63K |
ILA160.59 Million ≈ $430.55K |
1.851x | -- |
About Novolog Pharm-Up 1966 Ltd
Novolog (Pharm-Up 1966) Ltd provides healthcare services in Israel. The company operates through three divisions: Logistics, Healthcare Services, and Digital. The Logistics division engages in the import and distribution of pharmaceuticals and medical products; logistics of clinical trials and related services; provision of pharmaceutical services to customers; and sterilization and validation pr… Read more